Abstract
Just as genome-wide association studies (GWAS) grew from the field of genetic epidemiology, so too do epigenome-wide association studies (EWAS) derive from the burgeoning field of epigenetic epidemiology, with both aiming to understand the molecular basis for disease risk. While genetic risk of disease is currently unmodifiable, there is hope that epigenetic risk may be reversible and or modifiable. This review will take a look back at the origins of this field and revisit the past early efforts to conduct EWAS using the 27k Illumina methylation beadarrays, to the present where most investigators are using the 450k Illumina beadarrays and finally to the future where next generation sequencing based methods beckon. There have been numerous diseases, exposures and lifestyle factors investigated with EWAS, with several significant associations now identified. However, much like the GWAS studies, EWAS are likely to require large international consortium-based approaches to reach the numbers of subjects, and statistical and scientific rigor, required for robust findings.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Hindorff LA, MacArthur J, Morales J, Junkins HA, Hall PN, Klemm AK et al. A Catalog of Published Genome-Wide Association Studies. www.genome.gov/gwastudies. Accessed 9 Jan 2014
Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL et al (2013) Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 45:353–361, 361e351–352
Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K et al (2013) GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet 45:362–370, 370e361–362
Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M et al (2013) Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 45:385–391, 391e381–382
Issa JP (2000) The epigenetics of colorectal cancer. Ann N Y Acad Sci 910:140–153, discussion 153–155
Jablonka E, Lamb MJ (2002) The changing concept of epigenetics. Ann N Y Acad Sci 981:82–96
Michels KB (2010) The promises and challenges of epigenetic epidemiology. Exp Gerontol 45:297–301
Mill J, Heijmans BT (2013) From promises to practical strategies in epigenetic epidemiology. Nat Rev Genet 14:585–594
Relton CL, Davey Smith G (2010) Epigenetic epidemiology of common complex disease: prospects for prediction, prevention, and treatment. PLoS Med 7:e1000356
Vaiserman AM, Voitenko VP, Mekhova LV (2011) [Epigenetic epidemiology of age-related diseases]. Ontogenez 42:30–50
Verma M, Rogers S, Divi RL, Schully SD, Nelson S, Joseph Su L, et al (2014) Epigenetic research in cancer epidemiology: trends, opportunities, and challenges. Cancer Epidemiol Biomarkers Prev 23:223–233
Waterland RA (2008) Epigenetic epidemiology of obesity: application of epigenomic technology. Nutr Rev 66(Suppl 1):S21–S23
Waterland RA, Michels KB (2007) Epigenetic epidemiology of the developmental origins hypothesis. Annu Rev Nutr 27:363–388
Rakyan VK, Down TA, Balding DJ, Beck S (2011) Epigenome-wide association studies for common human diseases. Nat Rev Genet 12:529–541
Patel CJ, Bhattacharya J, Butte AJ (2010) An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus. PLoS One 5:e10746
Bogdanos DP, Smyk DS, Invernizzi P, Rigopoulou EI, Blank M, Pouria S et al (2013) Infectome: a platform to trace infectious triggers of autoimmunity. Autoimmun Rev 12:726–740
Rappaport SM (2012) Biomarkers intersect with the exposome. Biomarkers 17:483–489
Barnett C, Vanicek N, Polman R, Hancock A, Brown B, Smith L et al (2009) Kinematic gait adaptations in unilateral transtibial amputees during rehabilitation. Prosthet Orthot Int 33:135–147
Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S et al (2003) Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299:1753–1755
Cui H, Onyango P, Brandenburg S, Wu Y, Hsieh CL, Feinberg AP (2002) Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res 62:6442–6446
Cruz-Correa M, Cui H, Giardiello FM, Powe NR, Hylind L, Robinson A et al (2004) Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition. Gastroenterology 126:964–970
Jirtle RL (2004) IGF2 loss of imprinting: a potential heritable risk factor for colorectal cancer. Gastroenterology 126:1190–1193
Ito Y, Koessler T, Ibrahim AE, Rai S, Vowler SL, Abu-Amero S et al (2008) Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer. Hum Mol Genet 17:2633–2643
Chan TL, Yuen ST, Kong CK, Chan YW, Chan AS, Ng WF et al (2006) Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer. Nat Genet 38:1178–1183
Suter CM, Martin DI, Ward RL (2004) Germline epimutation of MLH1 in individuals with multiple cancers. Nat Genet 36:497–501
Kwok CT, Vogelaar IP, van Zelst-Stams WA, Mensenkamp AR, Ligtenberg MJ, Rapkins RW, et al (2014) The MLH1 c.-27C>A and c.85G>T variants are linked to dominantly inherited MLH1 epimutation and are borne on a European ancestral haplotype. Eur J Hum Genet 22:617–624
Ligtenberg MJ, Kuiper RP, Chan TL, Goossens M, Hebeda KM, Voorendt M et al (2009) Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. Nat Genet 41:112–117
Brennan K, Garcia-Closas M, Orr N, Fletcher O, Jones M, Ashworth A et al (2012) Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk. Cancer Res 72:2304–2313
Widschwendter M, Apostolidou S, Raum E, Rothenbacher D, Fiegl H, Menon U et al (2008) Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS One 3:e2656
Iwamoto T, Yamamoto N, Taguchi T, Tamaki Y, Noguchi S. (2011) BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation. Breast Cancer Res Treat 129:69–77
Snell C, Krypuy M, Wong EM, Loughrey MB, Dobrovic A (2008) BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype. Breast Cancer Res 10:R12
Wong EM, Southey MC, Fox SB, Brown MA, Dowty JG, Jenkins MA et al (2011) Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer. Cancer Prev Res (Phila) 4:23–33
Heijmans BT, Mill J (2012) Commentary: the seven plagues of epigenetic epidemiology. Int J Epidemiol 41:74–78
Michels KB, Binder AM, Dedeurwaerder S, Epstein CB, Greally JM, Gut I et al (2013) Recommendations for the design and analysis of epigenome-wide association studies. Nat Methods 10:949–955
Verma M (2012) Epigenome-Wide Association Studies (EWAS) in Cancer. Curr Genomics 13:308–313
Wilhelm-Benartzi CS, Koestler DC, Karagas MR, Flanagan JM, Christensen BC, Kelsey KT et al (2013) Review of processing and analysis methods for DNA methylation array data. Br J Cancer 109:1394–1402
Bell JT, Saffery R (2012) The value of twins in epigenetic epidemiology. Int J Epidemiol 41:140–150
Bock C (2012) Analysing and interpreting DNA methylation data. Nat Rev Genet 13:705–719
Jaffe AE, Murakami P, Lee H, Leek JT, Fallin MD, Feinberg AP et al (2012) Bump hunting to identify differentially methylated regions in epigenetic epidemiology studies. Int J Epidemiol 41:200–209
Ng JW, Barrett LM, Wong A, Kuh D, Smith GD, Relton CL (2012) The role of longitudinal cohort studies in epigenetic epidemiology: challenges and opportunities. Genome Biol 13:246
Ong ML, Holbrook JD. (2014) Novel region discovery method for Infinium 450k DNA methylation data reveals changes associated with aging in muscle and neuronal pathways. Aging Cell 13:142–155
Ramagopalan SV, Rakyan VK (2013) The promise and challenges of blood spot methylomics. Epigenetics 8:775–777
Talens RP, Boomsma DI, Tobi EW, Kremer D, Jukema JW, Willemsen G et al (2010) Variation, patterns, and temporal stability of DNA methylation: considerations for epigenetic epidemiology. FASEB J 24:3135–3144
Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D et al (2013) A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450k DNA methylation data. Bioinformatics 29:189–196
Zhuang J, Widschwendter M, Teschendorff AE (2012) A comparison of feature selection and classification methods in DNA methylation studies using the Illumina Infinium platform. BMC Bioinformatics 13:59
Lowe R, Gemma C, Beyan H, Hawa MI, Bazeos A, Leslie RD et al (2013) Buccals are likely to be a more informative surrogate tissue than blood for epigenome-wide association studies. Epigenetics 8:445–454
Koestler DC, Christensen B, Karagas MR, Marsit CJ, Langevin SM, Kelsey KT et al (2013) Blood-based profiles of DNA methylation predict the underlying distribution of cell types: a validation analysis. Epigenetics 8:816–826
Koestler DC, Marsit CJ, Christensen BC, Accomando W, Langevin SM, Houseman EA et al (2012) Peripheral blood immune cell methylation profiles are associated with nonhematopoietic cancers. Cancer Epidemiol Biomarkers Prev 21:1293–1302
Reinius LE, Acevedo N, Joerink M, Pershagen G, Dahlen SE, Greco D et al (2012) Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One 7:e41361
Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH et al (2012) DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics 13:86
Liu Y, Aryee MJ, Padyukov L, Fallin MD, Hesselberg E, Runarsson A et al (2013) Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat Biotechnol 31:142–147
Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, Cui H et al (2008) Intra-individual change over time in DNA methylation with familial clustering. JAMA 299:2877–2883
Feinberg AP, Irizarry RA, Fradin D, Aryee MJ, Murakami P, Aspelund T et al (2010) Personalized epigenomic signatures that are stable over time and covary with body mass index. Sci Transl Med 2:49ra67
Florath I, Butterbach K, Müller H, Bewerunge-Hudler M, Brenner H. (2014) Cross-sectional and longitudinal changes in DNA methylation with age: an epigenome-wide analysis revealing over 60 novel age-associated CpG sites. Hum Mol Genet 23:1186–1201
Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML et al (2005) Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 102:10604–10609
Bell JT, Tsai PC, Yang TP, Pidsley R, Nisbet J, Glass D et al (2012) Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet 8:e1002629
Bell CG, Finer S, Lindgren CM, Wilson GA, Rakyan VK, Teschendorff AE et al (2010) Integrated genetic and epigenetic analysis identifies haplotype-specific methylation in the FTO type 2 diabetes and obesity susceptibility locus. PLoS One 5:e14040
Schalkwyk LC, Meaburn EL, Smith R, Dempster EL, Jeffries AR, Davies MN et al (2010) Allelic skewing of DNA methylation is widespread across the genome. Am J Hum Genet 86:196–212
Hitchins MP, Rapkins RW, Kwok CT, Srivastava S, Wong JJ, Khachigian LM et al (2011) Dominantly inherited constitutional epigenetic silencing of MLH1 in a cancer-affected family is linked to a single nucleotide variant within the 5'UTR. Cancer Cell 20:200–213
Rakyan VK, Down TA, Maslau S, Andrew T, Yang TP, Beyan H et al (2010) Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res 20:434–439
Breitling LP, Yang R, Korn B, Burwinkel B, Brenner H (2011) Tobacco-smoking-related differential DNA methylation: 27k discovery and replication. Am J Hum Genet 88:450–457
Shenker NS, Polidoro S, van Veldhoven K, Sacerdote C, Ricceri F, Birrell MA et al (2013) Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking. Hum Mol Genet 22:843–851
Zhang Y, Yang R, Burwinkel B, Breitling LP, Brenner H. (2014) F2RL3 methylation as a biomarker of current and lifetime smoking exposures. Environ Health Perspect122:131–137
Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Gayther SA, Apostolidou S et al (2009) An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One 4:e8274
Marsit CJ, Koestler DC, Christensen BC, Karagas MR, Houseman EA, Kelsey KT (2011) DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer. J Clin Oncol 29:1133–1139
Langevin SM, Koestler DC, Christensen BC, Butler RA, Wiencke JK, Nelson HH et al (2012) Peripheral blood DNA methylation profiles are indicative of head and neck squamous cell carcinoma: an epigenome-wide association study. Epigenetics 7:291–299
Xu Z, Bolick SC, DeRoo LA, Weinberg CR, Sandler DP, Taylor JA (2013) Epigenome-wide association study of breast cancer using prospectively collected sister study samples. J Natl Cancer Inst 105:694–700
Garcia-Closas M, Gail MH, Kelsey KT, Ziegler RG (2013) Searching for blood DNA methylation markers of breast cancer risk and early detection. J Natl Cancer Inst 105:678–680
Brennan K, Flanagan JM (2012) Is there a link between genome-wide hypomethylation in blood and cancer risk? Cancer Prev Res (Phila) 5:1345–1357
Rakyan VK, Beyan H, Down TA, Hawa MI, Maslau S, Aden D et al (2011) Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet 7:e1002300
Hidalgo B, Irvin MR, Sha J, Zhi D, Aslibekyan S, Absher D, et al (2014) Epigenome-wide association study of fasting measures of glucose, insulin, and HOMA-IR in the Genetics of Lipid Lowering Drugs and Diet Network study. Diabetes 63:801–807
Hosokawa M, Yoshikawa T, Negishi R, Yoshino T, Koh Y, Kenmotsu H et al (2013) Microcavity array system for size-based enrichment of circulating tumor cells from the blood of patients with small-cell lung cancer. Anal Chem 85:5692–5698
Shenker NS, Ueland PM, Polidoro S, van Veldhoven K, Ricceri F, Brown R et al (2013) DNA methylation as a long-term biomarker of exposure to tobacco smoke. Epidemiology 24:712–716
Philibert RA, Beach SR, Brody GH (2012) Demethylation of the aryl hydrocarbon receptor repressor as a biomarker for nascent smokers. Epigenetics 7:1331–1338
Joubert BR, Haberg SE, Nilsen RM, Wang X, Vollset SE, Murphy SK et al (2012) 450k epigenome-wide scan identifies differential DNA methylation in newborns related to maternal smoking during pregnancy. Environ Health Perspect 120:1425–1431
Wan ES, Qiu W, Baccarelli A, Carey VJ, Bacherman H, Rennard SI et al (2012) Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome. Hum Mol Genet 21:3073–3082
Monick MM, Beach SR, Plume J, Sears R, Gerrard M, Brody GH et al (2012) Coordinated changes in AHRR methylation in lymphoblasts and pulmonary macrophages from smokers. Am J Med Genet B Neuropsychiatr Genet 159B:141–151
Philibert RA, Sears RA, Powers LS, Nash E, Bair T, Gerke AK et al (2012) Coordinated DNA methylation and gene expression changes in smoker alveolar macrophages: specific effects on VEGF receptor 1 expression. J Leukoc Biol 92:621–631
Haworth KE, Farrell WE, Emes RD, Ismail KM, Carroll WD, Borthwick HA et al (2013) Combined influence of gene-specific cord blood methylation and maternal smoking habit on birth weight. Epigenomics 5:37–49
Nishihara R, Morikawa T, Kuchiba A, Lochhead P, Yamauchi M, Liao X et al (2013) A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification. Am J Epidemiol 178:84–100
Philibert RA, Beach SR, Lei MK, Brody GH (2013) Changes in DNA methylation at the aryl hydrocarbon receptor repressor may be a new biomarker for smoking. Clin Epigenetics 5:19
Sun YV, Smith AK, Conneely KN, Chang Q, Li W, Lazarus A et al (2013) Epigenomic association analysis identifies smoking-related DNA methylation sites in African Americans. Hum Genet 132:1027–1037
Zeilinger S, Kuhnel B, Klopp N, Baurecht H, Kleinschmidt A, Gieger C et al (2013) Tobacco smoking leads to extensive genome-wide changes in DNA methylation. PLoS One 8:e63812
Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Weisenberger DJ, Shen H et al (2010) Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res 20:440–446
West J, Beck S, Wang X, Teschendorff AE (2013) An integrative network algorithm identifies age-associated differential methylation interactome hotspots targeting stem-cell differentiation pathways. Sci Rep 3:1630
Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda S et al (2013) Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell 49:359–367
Heyn H, Carmona FJ, Gomez A, Ferreira HJ, Bell JT, Sayols S, et al (2013) DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker. Carcinogenesis 34:102–108
Garagnani P, Bacalini MG, Pirazzini C, Gori D, Giuliani C, Mari D et al (2012) Methylation of ELOVL2 gene as a new epigenetic marker of age. Aging Cell 11:1132–1134
Esteller M (2011) Epigenetic changes in cancer. F1000 Biol Rep 3:9
Brennan K, Flanagan JM (2012) Epigenetic epidemiology for cancer risk: harnessing germline epigenetic variation. Methods Mol Biol 863:439–465
Beck S (2010) Taking the measure of the methylome. Nat Biotechnol 28:1026–1028
Acknowledgements
JMF is funded by Breast Cancer Campaign and Cancer Research UK.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Flanagan, J.M. (2015). Epigenome-Wide Association Studies (EWAS): Past, Present, and Future. In: Verma, M. (eds) Cancer Epigenetics. Methods in Molecular Biology, vol 1238. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1804-1_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1804-1_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1803-4
Online ISBN: 978-1-4939-1804-1
eBook Packages: Springer Protocols